A-A-53061
9 July 1987
COMMERCIAL ITEM DESCRIPTION
TEMAZEPAM CAPSULES
The General Services Administration has authorized the use of this Commercial Item Description.
Salient characteristics:
Shall be Temazepam Capsules.
All ingredients shall be of pharmaceutical grade.
For Strength 1, shall contain 15 mg of Temazepam per capsule, within the applicable assay limits for the capsules.
For Strength 2, shall contain 30 mg of Temazepam per capsule, within the applicable assay limits for the capsules.
Workmanship. The Capsules shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Bottle (BT).
For Size 1, one bottle containing 30 capsules, as specified, constitutes one unit. Bottle shall be supplied with a child-resistant safety closure.
For size 2, one bottle containing 500 capsules, as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business